Skip to main content

Month: January 2026

Linkhome Launches AI-Powered Mortgage Services on Its Platform

Irvine, California, Jan. 29, 2026 (GLOBE NEWSWIRE) — Linkhome Holdings Inc. (Nasdaq: LHAI) today announced the official launch of AI-powered mortgage services on its real estate platform. The new service allows users to access mortgage-related services directly through the Linkhome platform, further enhancing the Company’s end-to-end, technology-driven homebuying experience. The AI-powered mortgage services are provided through Linkhome Mortgage Inc., a wholly owned subsidiary acquired by Linkhome Holdings Inc. Linkhome Mortgage Inc. is a licensed U.S. mortgage company registered with the Nationwide Multistate Licensing System (NMLS). The company has initially been authorized to conduct mortgage-related business in the State of California and operates in full compliance with applicable state and federal regulatory requirements. With...

Continue reading

EagleNXT Drones Supporting Wildlife and Agriculture Monitoring Operations

Idaho Department of Fish and Game (IDFG) Enhancing Capabilities with Advanced eBee Drone ALLEN, Texas, Jan. 29, 2026 (GLOBE NEWSWIRE) — AgEagle Aerial Systems Inc. (dba, EagleNXT) (the “Company” or “EagleNXT”) (NYSE: UAVS), a leading provider of full stack drone, sensors and software solutions for customers worldwide in the commercial and government verticals, today announces the Idaho Department of Fish and Game (IDFG) is acquiring an eBee X drone. This acquisition supports IDFG’s efforts to monitor and reduce crop depredation on private agricultural lands caused by big game species such as elk, deer, and moose. The move directly supports IDFG’s statutory mission to preserve, protect, and manage Idaho’s wildlife resources, including addressing human-wildlife interaction where big game animals cause economic losses...

Continue reading

Greenridge Provides Update on 2025 Athabasca Basin Region Exploration Activities

VANCOUVER, British Columbia, Jan. 29, 2026 (GLOBE NEWSWIRE) — Greenridge Exploration Inc. (“Greenridge” or the “Company“) (CSE: GXP | OTC: GXPLF | FRA: HW3), is pleased to provide an update on its uranium and critical metals exploration activities completed in 2025 in the Athabasca Basin region of Saskatchewan, Canada. Russell Starr, Chief Executive Officer of the Company, commented: “In 2025, Greenridge conducted an extensive exploration program across six projects in northern Saskatchewan, employing advanced technologies to establish a robust geological dataset to support future drilling initiatives. The Company commends the dedication and expertise of its exploration team, contractors, and exploration partners, and looks forward to advancing these results into the 2026 field season.”Greenridge’s Exploration...

Continue reading

SunPower National Battery Storage Initiative

With Palmetto LightReach, The Cool Down, and Enphase Energy OREM, Utah, Jan. 29, 2026 (GLOBE NEWSWIRE) — SunPower (herein “SunPower,” the “Company,” or Nasdaq: “SPWR”), a solar technology, services, and installation company, today announced a strategic initiative to make home battery storage more accessible to American families. The company has engaged The Cool Down, a lifestyle media platform with a large homeowner audience; Palmetto, a consumer energy platform; and Enphase Energy, (Nasdaq: “ENPH”), which manufactures the state-of-the-art IQ Battery 10C. As it has for decades, SunPower has developed strategic partnerships to accelerate solar technology adoption. This initiative is designed to give homeowners access to premium battery systems with flexible financing options to make batteries more affordable. As AI power usage exacerbates...

Continue reading

Revolution Medicines Doses First Patient in Clinical Trial Evaluating RMC-5127, a RAS(ON) G12V-Selective Inhibitor

REDWOOD CITY, Calif., Jan. 29, 2026 (GLOBE NEWSWIRE) — Revolution Medicines, a late-stage clinical oncology company developing targeted therapies for patients with RAS-addicted cancers, today announced the first patient was dosed in its first-in-human clinical trial evaluating RMC-5127, a RAS(ON) G12V-selective inhibitor. The first-in-human trial, RMC-5127-001 [NCT07349537], is an open-label trial evaluating the safety, tolerability, pharmacokinetics, and preliminary antitumor activity of RMC-5127 as both a monotherapy and in combination settings. The trial will enroll patients with RAS G12V–mutated solid tumors, including pancreatic ductal adenocarcinoma (PDAC), colorectal cancer (CRC), and non–small cell lung cancer (NSCLC), who have progressed on or are intolerant to prior standard therapies, including targeted treatments. “By...

Continue reading

Parker Reports Fiscal 2026 Second Quarter Results

Record Sales and Segment Operating Margin Drive Adjusted EPS Growth CLEVELAND, Jan. 29, 2026 (GLOBE NEWSWIRE) — Parker Hannifin Corporation (NYSE: PH), the global leader in motion and control technologies, today reported results for the quarter ended December 31, 2025, that included the following highlights (compared with the prior year period): Fiscal 2026 Second Quarter Highlights:Sales increased 9% to a record $5.2 billion; organic sales increased 6.6% Segment operating margin was 23.9%, an increase of 180 bps, or 27.1% adjusted, an increase of 150 bps Net income was $845 million, a decrease of 11% compared with the second quarter of fiscal 2025 which included a one-time after-tax gain from divestitures of $223 million Adjusted net income increased 15% to $980 million EPS were $6.60, a decrease of 9% compared with the second...

Continue reading

3 E Network Launches Intellisight™ Platform for AI Compute Infrastructure with AIOps and Active Security

HONG KONG, Jan. 29, 2026 (GLOBE NEWSWIRE) — 3 E Network Technology Group Limited (Nasdaq: MASK, “3 E” or the “Company”), a business-to-business (“B2B”) information technology (“IT”) business solutions provider advancing toward next-generation artificial intelligence (“AI”) infrastructure solutions, today officially announced the launch of its proprietary 3 E Intellisight™ Intelligent Operations Platform (the “3 E Intellisight™ Platform”). By integrating real-time IoT telemetry, artificial intelligence and data analytics, the platform is designed to provide automated operations and security management capabilities for high-density AI computing clusters. The platform is intended to support infrastructure monitoring, incident response and network...

Continue reading

FG Nexus Named #1 Among Successful Repeat SPAC Sponsors

Establishes Leadership Position in SPAC Market with Proven Track Record and Strategic Vision Charlotte, NC, Jan. 29, 2026 (GLOBE NEWSWIRE) — FG Nexus Inc. (Nasdaq: FGNX, FGNXP) (the “Company”) today announced it has been recognized as the top-performing SPAC sponsor by median returns and the second-ranking sponsor by average returns, according to a comprehensive industry study conducted by EarlyBirdCapital. Under the leadership of Larry Swets, Head of Merchant Banking, and the other partners of FG Merchant Partners, including Hassan Baqar, Kyle Cerminara, and Joe Moglia, FG Nexus has established a differentiated and long-standing track record in the SPAC ecosystem. The four partners of FG Merchant Partners collectively bring deep leadership, operational, finance, and investment management expertise, and as early adopters of the...

Continue reading

InflaRx Announces Participation in February Investor Conferences

JENA, Germany, Jan. 29, 2026 (GLOBE NEWSWIRE) — InflaRx N.V. (Nasdaq: IFRX), a biopharmaceutical company pioneering anti-inflammatory therapeutics by targeting the complement system, today announced it will participate in several investor conferences in February 2026. Details are as follows: Guggenheim Securities Emerging Outlook: Biotech Summit 2026February 11 – 12, 2026 in New York, NYFireside chat on Wednesday, February 11 at 11:30 AM ET InflaRx will also conduct one-on-one investor meetings on February 11th. A link to view the fireside chat live stream and its replay is available here. Oppenheimer 36th Annual Healthcare Life Sciences ConferenceFebruary 25 – 26, 2026 in a virtual formatVirtual presentation on February 25 at 8:40 AM ET InflaRx will also conduct one-on-one investor meetings on February 25th. A link...

Continue reading

Glass House Brands Announces Appointment of Alison Payne, Heineken USA Chief Marketing Officer, to its Board of Directors

Ms. Payne brings decades of international marketing experience from Heineken, PepsiCo, Kellog and Diageo, where she specializes in branding regulated consumer products LONG BEACH, Calif. and TORONTO, Jan. 29, 2026 (GLOBE NEWSWIRE) — Glass House Brands Inc. (“Glass House” or the “Company”) (CBOE CA: GLAS.A.U) (CBOE CA: GLAS.WT.U) (OTCQX: GLASF) (OTCQX:GHBWF), one of the fastest-growing, vertically-integrated cannabis companies in the U.S., today announced the appointment of Alison Payne, a seasoned branding and marketing leader, to its Board of Directors effective January 27, 2026. Ms. Payne fills the vacant seat on the Company’s Board vacated by the passing of long-term Board Member George Raveling in September 2025. “Alison is a great person with proven ability to build brands, lead with innovation, and achieve results. She is...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.